Veoza®
45mg | Tablets

From May 1st 2026, VEOZA® 45 mg is fully reimbursed by the health insurance (exclusively for an insured person with moderate to severe vasomotor symptoms associated with menopause and a contraindication to hormone replacement therapy). For this reason the reimbursement scheme for VEOZA® will terminate the 1st of May 2026.
| Dose | VEOZA® 45mg |
| Type | Tablets |
| Active ingredient | FEZOLINETANT |
The Personal Contribution for VEOZA® that is demonstrably charged to the patient was fully reimbursed until May 1st 2026. Prescriptions dispensed until May 1st 2026 can be claimed through TerugBetaalRegeling Nederland until July 31st 2026.
Claims with an issue date before the 1 st of May 2026 can be processed by TBR Nederland until July 31, 2026.
Patients and pharamcists can claim online and will receive the reimbursement within 5 working days.
If you need any assistance please read our Frequently Asked Questions or watch the Instructional Videos.
Still does not work? Please contact our Servicedesk via e-mail or call the VEOZA® service-number 088 - 0026767.
Watch our instructional videos for more information about creating an account and making a claim
Quickly check the maximum contribution you have to pay for your medicine